Central Analgesic Drugs for the Treatment of Chronic Pain
Cognitive Study on the Use of Central Analgesic Drugs in the Management of Chronic Pain
1 other identifier
observational
300
0 countries
N/A
Brief Summary
Chronic pain is defined as pain that persists after healing of the wound that caused it, and can occur even in the absence of any obvious pathological trigger. In our country, there is a growing interest in the proper management of the disease "pain". Pain is also the first symptom of the disease in 20 -50% of patients with neoplastic disease and from 75% to 90% of patients with advanced cancer suffers from chronic pain . However, pain management is mostly inadequate. This study aims to assess the Italian clinical practice in reference to the pharmacological management of chronic pain by health professionals involved in the treatment of pain in some centers belonging to the Italian network of pain therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2014
CompletedFirst Posted
Study publicly available on registry
August 22, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedAugust 22, 2014
November 1, 2012
1.4 years
August 20, 2014
August 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
adherence to therapy
to evaluate the proportion of patients who continues therapy with benefit after one month of enrollment
18 months
Secondary Outcomes (3)
adherence at 6 months
18 months
side effects
18 months
quality of life
18 months
Eligibility Criteria
patients with persistent pain syndromes (chronic pain) followed on an outpatient / DH at some Italian centers of Pain Therapy
You may qualify if:
- Males and females over the age of 18 years
- Chronic neuropathic and / or nociceptive and / or mixed pain, whereby clinicians considers necessary to start opioid therapy
- Signed informed consent
You may not qualify if:
- Males and females aged under 18 years
- Patients already receiving opioid analgesic drugs or drugs of the class MOR-NRI.
- Taking abuse drugs or alcohol abuse
- Patients with contraindications to the use of central analgesic drugs
- Patients who refuse participation
- Prior cognitive impairment or mental retardation
- Severe immunodeficiency (WBC \<4,000)
- Severe renal impairment (serum creatinine \> 2g/dl or Creatinine clearance \<30 ml / h)
- Hepatic impairment (Cholinesterase \<2.000UI or INR\> 2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Compagnone
University of Parma
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 20, 2014
First Posted
August 22, 2014
Study Start
September 1, 2014
Primary Completion
February 1, 2016
Study Completion
February 1, 2017
Last Updated
August 22, 2014
Record last verified: 2012-11